Katopodis KP - Search Results

1

Patient clearance time (tp) with different vascular access types.

Dounousi EC, Balafa OC, Gouva CD, Karassavidou DP, Mitsis MC, Pappas EM, Katopodis KP. Dounousi EC, et al. Among authors: katopodis kp. Int J Artif Organs. 2013 Dec;36(12):853-60. doi: 10.5301/ijao.5000247. Epub 2013 Oct 2. Int J Artif Organs. 2013. PMID: 24366836

2

Acute effect of heparin on lipid parameters in patients on renal replacement therapy.

Katopodis KP, Koliousi E, Gouva C, Balafa O, Bairaktari E, Ikonomou M, Elisaf MS, Siamopoulos KC. Katopodis KP, et al. ASAIO J. 2007 Jan-Feb;53(1):46-9. doi: 10.1097/01.mat.0000247155.20214.20. ASAIO J. 2007. PMID: 17237649

3

Switch from conventional to every other day hemodialysis: a comparison pilot study.

Katopodis KP, Dounousi E, Challa A, Pappas K, Kalaitzidis R, Siamopoulos KC. Katopodis KP, et al. ASAIO J. 2009 Jan-Feb;55(1):41-6. doi: 10.1097/MAT.0b013e318191f153. ASAIO J. 2009. PMID: 19092650 Clinical Trial.

4

Estimation of Residual Peritoneal Volume Using Technetium-99m Sulfur Colloid Scintigraphy.

Katopodis KP, Fotopoulos AD, Balafa OC, Tsiouris ST, Triandou EG, Al-Bokharhli JB, Kitsos AC, Dounousi EC, Siamopoulos KC. Katopodis KP, et al. ASAIO J. 2015 Jul-Aug;61(4):459-62. doi: 10.1097/MAT.0000000000000221. ASAIO J. 2015. PMID: 25806615

5

Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance.

Pappas KD, Gouva CD, Katopodis KP, Nikolopoulos PM, Korantzopoulos PG, Michalis LK, Goudevenos JA, Siamopoulos KC. Pappas KD, et al. Among authors: katopodis kp. Cardiovasc Drugs Ther. 2008 Feb;22(1):37-44. doi: 10.1007/s10557-007-6075-6. Epub 2007 Dec 20. Cardiovasc Drugs Ther. 2008. PMID: 18095148 Clinical Trial.

6

Inorganic phosphorus homeostasis during the first hour of dialysis.

Katopodis KP, Dounousi EC, Challa AS, Vlachou IA, Karasavvidou DP. Katopodis KP, et al. Ren Fail. 2011;33(6):562-7. doi: 10.3109/0886022X.2011.584647. Ren Fail. 2011. PMID: 21663386 Free article.

7

The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients.

Pappas EM, Mpournaka S, Katopodis P, Chardalias A, Tsakas S, Theodoros T, Evangelos E, Katopodis KP, Goumenos DS. Pappas EM, et al. Among authors: katopodis kp. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):25-32. doi: 10.2478/prilozi-2019-0011. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019. PMID: 31605588 Free article.

8

Acid-base abnormalities and liver dysfunction.

Katopodis P, Pappas EM, Katopodis KP. Katopodis P, et al. Among authors: katopodis kp. Ann Hepatol. 2022 Mar-Apr;27(2):100675. doi: 10.1016/j.aohep.2022.100675. Epub 2022 Jan 21. Ann Hepatol. 2022. PMID: 35074477 Free article. Review.

9

Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.

Katopodis KP, Elisaf M, Balafa O, Nikolopoulos P, Bairaktari E, Katsaraki A, Siamopoulos KC. Katopodis KP, et al. Am J Nephrol. 2004 Sep-Oct;24(5):469-73. doi: 10.1159/000080591. Epub 2004 Aug 5. Am J Nephrol. 2004. PMID: 15345918 Clinical Trial.

10

Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients.

Katopodis KP, Andrikos EK, Gouva CD, Bairaktari ET, Nikolopoulos PM, Takouli LK, Tzallas CS, Elisaf MS, Pappas MV, Siamopoulos KC. Katopodis KP, et al. Perit Dial Int. 2006 May-Jun;26(3):320-7. Perit Dial Int. 2006. PMID: 16722024 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters